Is nitroxyl anion involved in myocardial protection against ischaemia/reperfusion injury in isolated rat hearts?

University of Bristol (2001) J Physiol 536P, S004

Communications: Is nitroxyl anion involved in myocardial protection against ischaemia/reperfusion injury in isolated rat hearts?

Pasquale Pagliaro, Daniele Mancardi, Raffaella Rastaldo and Nazareno Paolocci*

Dipartimento di Scienze Cliniche e Biologiche, University of Turin, Italy and *Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, USA

View other abstracts by:


It has been reported that reactive nitrogen oxide species can lead to ischaemic preconditioning (IP) (Pagliaro et al. 2001). However, it is unknown whether nitroxyl anion (NO), the one-electron reduction product of nitric oxide (NO), is involved in protection by IP. Since NO can be generated from chemical reactions that occur in vivo, which are influenced by tissue redox conditions, we tested whether NO may also trigger the protective effects of IP in isolated rat hearts.

Twenty-four male Wistar rats, 5-6 months old (450-550 g body weight), were decapitated after urethane (0.5 g I.P.) anaesthesia. Then the hearts were excised, suspended as Langendorff preparations, retrogradely perfused at constant flow (9 ± 1 ml min-1 g-1) with Tyrode oxygenated solution at 37 °C, and paced at 280 b.p.m. A polyvinyl chloride balloon was placed in the left ventricle via the mitral valve to record left ventricular pressure (LVP). Angeli’s salt (AS) was used to generate NO in solution.

The hearts were divided into three groups. All hearts underwent ischaemia/reperfusion (I/R) consisting of 30 min of global ischaemia and 30 min of reperfusion. In Group 1 (n = 9), I/R was preceded by 19 min of infusion of the vehicle used for AS; in Group 2 (n = 7) I/R was preceded by three cycles of 3 min of global ischaemia followed by 5 min reperfusion; in Group 3 (n = 8), I/R was preceded by 19 min of infusion of AS (1 mM). The size of the infarct produced by I/R was assessed on slices of left ventricle incubated in nitro-blue tetrazolium (0.1 % in phosphate buffer). Statistical analysis was performed by one-way ANOVA with Bonferroni correction. Data are means ± S.E.M.

As seen in vivo (Paolocci et al. 2001), AS per se exerted a positive inotropic effect revealed by a ¦10 % (P < 0.05) increase in developed LVP. However, post-ischaemic reduction in developed LVP was not different in the three groups. In contrast, during ischaemia end-diastolic LVP increased by 11 ± 5 mmHg in Group 1, by 8 ± 3 in Group 2 and only by 6 ± 3 in Group 3. The limited increase of end-diastolic LVP in preconditioned and in AS-pretreated hearts was considered an index of limited contracture due to increased resistance to ischaemia. In fact, while in Group 1 necrotic tissue was 30 ± 3 %, it was only 12 ± 3 % in Group 2 (P < 0.01 vs. Group 1), and 19 ± 2 % in Group 3 (P = n.s. vs. IP; P < 0.05 vs. Group 1). Our data are consistent with NO being a preconditioning agent and support the hypothesis that NO production is enhanced during IP and contributes to the triggering of protection.

    Pagliaro, P., Gattullo, D., Rastaldo, R. & Losano, G. (2001). Life Sci. 69, 1-15.

    Paolocci, N., Saavedra, F.W., Miranda, K.M., Martignani, C., Isoda, T., Hare, J.M., Espey, M.G., Fukuto, J.M., Feelisch, M., Wink, D.A. & Kass, D.A. (2001). Proc. Natl Acad. Sci. USA 98, 10463-10468.



Where applicable, experiments conform with Society ethical requirements.

Site search

Filter

Content Type